Results 111 to 120 of about 24,208,296 (151)

Understanding Atomoxetine Exposure Variability in Children and Adolescents With ADHD Through Population Pharmacokinetics. [PDF]

J Clin Pharmacol
Tobin KV, Pritchett A, Leeder JS, Gobburu J, Dunn A.   +4 more
europepmc   +1 more source

Herbicide resistance and cytochrome P-450

, 1993
Hallahan, D. L., Hyde, R. J., Bowyer, J. R., Cheriton, A. K.   +3 more
core  

Impact of Mild Traumatic Brain Injury (mTBI) on CYP2D6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation. [PDF]

Iran J Pharm Res
Berenjian K, Gholipour Z, Khoshayand M, Sharifzadeh M, Rouini M, Hosseinzadeh Ardakani Y.   +5 more
europepmc   +1 more source

Integrated assessment of rifampicin-mediated induction of transporters and drug-metabolizing enzymes in a long-term human liver tissue chip system. [PDF]

Clin Pharmacol Ther
Hartauer ME, Lanphier RM, Ohri S, Snyder J, Tiley JB, Fallon JK, Ho H, Cirit M, Rajan SAP, Brouwer KLR.   +9 more
europepmc   +1 more source

Pharmacokinetic Drug-Drug Interactions of DA-8010 with Clarithromycin or Rifampicin: Influence of CYP2D6 Phenotype on the Extent of These Interactions. [PDF]

Drug Des Devel Ther
Lee S, Won H, Yu KS, Lee DY, Lee S.
europepmc   +1 more source

Differential impact of Tafenoquine and Primaquine on <i>Plasmodium vivax</i> recurrence: the role of <i>CYP2D6</i> variants. [PDF]

Antimicrob Agents Chemother
Godinho VKC, Mwangi VI, Morais MC, Lopes APB, Alves JRdS, Brito MAM, Lacerda MVGd, Trindade Maranhão Costa F, Almeida ACGd, Melo GCd.   +9 more
europepmc   +1 more source

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole. [PDF]

Schizophr Bull
Gras C, Piras M, Ranjbar S, Grosu C, Girardin FR, Vandenberghe F, Ansermot N, Grandjean C, Kaiser S, Gamma F, Plessen KJ, von Gunten A, Conus P, Crettol S, Eap CB.   +14 more
europepmc   +1 more source

Improving hepatic metabolic function with 3D iPSC-derived human hepatocytes. [PDF]

Cell Biol Toxicol
Pozo Garcia V, Kiamehr M, Versteegden R, Naderlinger E, Jennings P, Verfaillie C, Vos JC, Moco S.   +7 more
europepmc   +1 more source

Associations between antihypertensive drug-related gene polymorphisms and cardiovascular outcomes in hypertensive patients: a gene-drug interaction study. [PDF]

Sci Rep
Li Z, Liu H, Chen M, Deng J, Ma Z, Huang G, Li C, Su M, Zhong H.   +8 more
europepmc   +1 more source

Effects of Cedirogant on the Pharmacokinetics of Sensitive Cytochrome P450 Probe Substrates. [PDF]

Clin Pharmacol Drug Dev
D'Cunha R, Qian Y, Hao S, Eccleston J, Levy GF, Gannu S, Rizzo DG, Liu W, Mohamed MF.   +8 more
europepmc   +1 more source